Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical relevance of liver histopathology and different histological classifications of NASH in adults
Fabio Nascimbeni, Stefano Ballestri, Mariana Verdelho Machado, et al.
Expert Review of Gastroenterology & Hepatology (2017) Vol. 12, Iss. 4, pp. 351-367
Closed Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

Links between metabolic syndrome and metabolic dysfunction-associated fatty liver disease
Soo Lim, Jin‐Wook Kim, Giovanni Targher
Trends in Endocrinology and Metabolism (2021) Vol. 32, Iss. 7, pp. 500-514
Closed Access | Times Cited: 150
Progress and challenges in the prevention and control of nonalcoholic fatty liver disease
Jingjing Cai, Xiao‐Jing Zhang, Hongliang Li
Medicinal Research Reviews (2018) Vol. 39, Iss. 1, pp. 328-348
Open Access | Times Cited: 130
Epidemiology and pathophysiology of the association between NAFLD and metabolically healthy or metabolically unhealthy obesity
Amedeo Lonardo, Alessandro Mantovani, Simonetta Lugari, et al.
Annals of Hepatology (2020) Vol. 19, Iss. 4, pp. 359-366
Open Access | Times Cited: 122
NAFLD in Some Common Endocrine Diseases: Prevalence, Pathophysiology, and Principles of Diagnosis and Management
Amedeo Lonardo, Alessandro Mantovani, Simonetta Lugari, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 11, pp. 2841-2841
Open Access | Times Cited: 98
Liver Fibrosis Biomarkers Accurately Exclude Advanced Fibrosis and Are Associated with Higher Cardiovascular Risk Scores in Patients with NAFLD or Viral Chronic Liver Disease
Stefano Ballestri, Alessandro Mantovani, Enrica Baldelli, et al.
Diagnostics (2021) Vol. 11, Iss. 1, pp. 98-98
Open Access | Times Cited: 73
Liver fibrosis in nonalcoholic fatty liver disease patients: noninvasive evaluation and correlation with cardiovascular disease and mortality
Stefano Ballestri, Alessandro Mantovani, Maria Di Girolamo, et al.
Metabolism and Target Organ Damage (2023) Vol. 3, Iss. 1, pp. 1-1
Open Access | Times Cited: 27
A round trip from nonalcoholic fatty liver disease to diabetes: molecular targets to the rescue?
Amedeo Lonardo, Simonetta Lugari, Stefano Ballestri, et al.
Acta Diabetologica (2018) Vol. 56, Iss. 4, pp. 385-396
Closed Access | Times Cited: 80
Statins and nonalcoholic fatty liver disease in the era of precision medicine: More friends than foes
Fabio Nascimbeni, Elisa Pellegrini, Simonetta Lugari, et al.
Atherosclerosis (2019) Vol. 284, pp. 66-74
Closed Access | Times Cited: 73
A critical appraisal of the use of ultrasound in hepatic steatosis
Stefano Ballestri, Fabio Nascimbeni, Simonetta Lugari, et al.
Expert Review of Gastroenterology & Hepatology (2019) Vol. 13, Iss. 7, pp. 667-681
Closed Access | Times Cited: 48
Renaming NAFLD to MAFLD: Could the LDE System Assist in This Transition?
Amedeo Lonardo
Journal of Clinical Medicine (2021) Vol. 10, Iss. 3, pp. 492-492
Open Access | Times Cited: 34
Liver fibrosis as a barometer of systemic health by gauging the risk of extrahepatic disease
Amedeo Lonardo, Stefano Ballestri, György Baffy, et al.
Metabolism and Target Organ Damage (2024) Vol. 4, Iss. 4
Open Access | Times Cited: 5
Bidirectional Association between Nonalcoholic Fatty Liver Disease and Gallstone Disease: A Cohort Study
Yoosoo Chang, Yoogyeong Oh, Byung-Seong Suh, et al.
Journal of Clinical Medicine (2018) Vol. 7, Iss. 11, pp. 458-458
Open Access | Times Cited: 44
Association between Sleep Disturbances and Liver Status in Obese Subjects with Nonalcoholic Fatty Liver Disease: A Comparison with Healthy Controls
Bertha Araceli Marín-Alejandre, Itziar Abete, Irene Cantero, et al.
Nutrients (2019) Vol. 11, Iss. 2, pp. 322-322
Open Access | Times Cited: 41
Metabolic syndrome and biochemical changes among non-alcoholic fatty liver disease patients attending a tertiary care hospital of Nepal
Bashu Dev Pardhe, Shreena Shakya, Anjeela Bhetwal, et al.
BMC Gastroenterology (2018) Vol. 18, Iss. 1
Open Access | Times Cited: 38
The interplay between metabolic dysregulations and non-alcoholic fatty liver disease in women after menopause
Ralitsa Robeva, Dušan Mladenović, Milena Vesković, et al.
Maturitas (2021) Vol. 151, pp. 22-30
Closed Access | Times Cited: 32
Histological assessment based on liver biopsy: the value and challenges in NASH drug development
Xiaofei Tong, Qianyi Wang, Xinyan Zhao, et al.
Acta Pharmacologica Sinica (2022) Vol. 43, Iss. 5, pp. 1200-1209
Open Access | Times Cited: 22
Perspectives of nonalcoholic fatty liver disease research: a personal point of view
Amedeo Lonardo, Stefano Ballestri
Exploration of Medicine (2020) Vol. 1, Iss. 3, pp. 85-107
Open Access | Times Cited: 32
Male-specific association between subclinical hypothyroidism and the risk of non-alcoholic fatty liver disease estimated by hepatic steatosis index: Korea National Health and Nutrition Examination Survey 2013 to 2015
Jeongmin Lee, Jeonghoon Ha, Kwanhoon Jo, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 30
High Keratin 8/18 Ratio Predicts Aggressive Hepatocellular Cancer Phenotype
Nicole Golob‐Schwarzl, Kira Bettermann, Anita K. Mehta, et al.
Translational Oncology (2018) Vol. 12, Iss. 2, pp. 256-268
Open Access | Times Cited: 30
Collagen deposition in the liver is strongly and positively associated with T1rho elongation while fat deposition is associated with T1rho shortening: an experimental study of methionine and choline-deficient (MCD) diet rat model
Feng Zhao, Nan Zhou, Jili Wang, et al.
Quantitative Imaging in Medicine and Surgery (2020) Vol. 10, Iss. 12, pp. 2307-2321
Open Access | Times Cited: 24
HbA1C as a Biomarker of Non-alcoholic Fatty Liver Disease: Comparison with Anthropometric Parameters
Muhammad Masroor, Zeba Haque
Journal of Clinical and Translational Hepatology (2021) Vol. 000, Iss. 000, pp. 1-7
Open Access | Times Cited: 17
Precision medicine in nonalcoholic fatty liver disease
Amedeo Lonardo
Journal of Gastroenterology and Hepatology (2022) Vol. 37, Iss. 7, pp. 1175-1178
Open Access | Times Cited: 12
Clinicopathologic characteristics of severe COVID-19 patients in Mexico City: A post-mortem analysis using a minimally invasive autopsy approach
Carlos A Nava-Santana, María Rodríguez-Armida, José Víctor Jiménez, et al.
PLoS ONE (2022) Vol. 17, Iss. 3, pp. e0262783-e0262783
Open Access | Times Cited: 10
Endocan: A Biomarker for Hepatosteatosis in Patients with Metabolic Syndrome
Hande Erman, Engin Beydogan, Seher Irem Cetin, et al.
Mediators of Inflammation (2020) Vol. 2020, pp. 1-7
Open Access | Times Cited: 15
Metabolically healthy and unhealthy obesity and the progression of liver fibrosis: A cross-sectional study
Helda Tutunchi, Fatemeh Naeini, Mehrangiz Ebrahimi‐Mameghani, et al.
Clinics and Research in Hepatology and Gastroenterology (2021) Vol. 45, Iss. 6, pp. 101754-101754
Closed Access | Times Cited: 14
Page 1 - Next Page

Scroll to top